Collectively, these observations support a model in which IDO production, either by dendritic cells or by AML cells promotes immune evasion by directly inhibiting proliferation of tumor-specific T cells, or indirectly by promoting Treg induction and/or suppressive capability. The gene discussed is IDO1; the disease is neoplasm.